TCL Archive Chemoprevention Concept Approved By DCPC Bard Uses Biological Markers To Assess Risk Modulation September 27, 1985
TCL Archive Angiogenesis Inhibitor In Phase III Trials For Metastatic Colorectal Cancer September 26, 2003